BRINZAX-B

COMPOSITION:- Brinzolamide 10mg &Brimonidine Tartrate2mg Ophthalmic Suspension(Withtray)
PACKAGE:- 5ml

Devaksh Lifesciences provides BRINZAX-B, a superior ophthalmic suspension that is intended to be used in the complex treatment of Glaucoma. This combination involves the use of two different mechanisms to decrease the intraocular pressure (IOP): Brinzolamide decreases the production of aqueous humor, and Brimonidine enhances its drainage and offers neuroprotective effects. This two fold activity plays a crucial role in maintaining the well-being of the optic nerve and in the long-term vision.

Key Features:

• Multi-mechanism method of the intraocular pressure lowering.
• Suspension formula which is ocularly comfortable.
• Gives the neuro protection to aid in preserving the optic nerve.
• Powerful pressure management in 24 hours.

Benefits & Advantages:

• Majorly decreases the number of chronic patients on daily drop burden.
  • Better than either of the two components as a monotherapy.
  • Reduces the chances of progressive loss of the visual field.
  • Extremely stable formula to achieve consistent results and dosage.

Usage & Clinical Highlights:

• Open-Angle Glaucoma and Ocular Hypertension Primary treatment.
• Intended to be used on patients who need the substantial IOP reduction to achieve target pressure.
• Clinically demonstrated to be well tolerated and low irritation rate.
• Best used in long term management when the protection of the optic nerves is desired.
• Applicable to patients who are not sufficiently managed using beta-blockers.